Anixa Biosciences, Inc. (ANIX) NASDAQ
2.55
-0.15(-5.56%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.55
-0.15(-5.56%)
Currency In USD
| Market Cap | 134.04M |
| Enterprise Value | 133M |
| P/E Ratio | -8.22 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 5.62 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -7.63 |
| Fiscal Year | October 31, 2025 |
| Most Recent Quarter | January 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.68 |
| Return On Equity | -0.66 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -36,000 |
| EBITDA | -11.7M |
| Net Income | -10.93M |
| Diluted EPS | -0.34 |
| Total Cash | 14.2M |
| Total Cash/Share | 0.43 |
| Total Debt | 193,000 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 12.18 |
| Book Value Per Share | 0.42 |
| 52-Week Change | -11.76 |
| 52-Week High | 5.46 |
| 52-Week Low | 2.44 |
| Moving Average 50 Days | 2.82 |
| Moving Average 200 Days | 3.33 |
| Average Volume | 108,768 |
| Shares Outstanding | 33.53M |
| % Held by Institutions | 15.36 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | June 26, 2015 |